These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 18761705)
41. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study. Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986 [TBL] [Abstract][Full Text] [Related]
43. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Bredenoord AJ; Hemmink GJ; Smout AJ Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635 [TBL] [Abstract][Full Text] [Related]
44. Differences in salivary secretion and epidermal growth factor concentrations in mild reflux esophagitis and non-erosive reflux disease. Koeda M; Momma E; Tanabe T; Kitasako Y; Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K Esophagus; 2023 Apr; 20(2):317-324. PubMed ID: 36344779 [TBL] [Abstract][Full Text] [Related]
45. Secretion of epidermal growth factor in saliva of duodenal ulcer patients; an association with Helicobacter pylori eradication and erosive esophagitis. Kiluk A; Namiot DB; Namiot Z; Leszczyńska K; Kurylonek AJ; Kemona A Adv Med Sci; 2008; 53(2):305-9. PubMed ID: 18930874 [TBL] [Abstract][Full Text] [Related]
46. The clinical usefulness of the ZAP classification for non-erosive reflux disease (NERD), using distal esophageal biopsy. Kim BJ; Rheez PL; Lee H; Kim JH; Son HJ; Chang DK; Kim YH; Kim JJ; Rhee JC; Kim JH Hepatogastroenterology; 2009; 56(90):385-9. PubMed ID: 19579604 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the different characteristics of sensed reflux events among different heartburn groups. Schey R; Shapiro M; Navarro-Rodriguez T; Fass SS; Han B; Wendel C; Fass R J Clin Gastroenterol; 2009 Sep; 43(8):699-704. PubMed ID: 18797407 [TBL] [Abstract][Full Text] [Related]
48. Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients. Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K Esophagus; 2021 Oct; 18(4):900-907. PubMed ID: 33886014 [TBL] [Abstract][Full Text] [Related]
49. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect. Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751 [TBL] [Abstract][Full Text] [Related]
50. Saliva variations in gastro-oesophageal reflux disease. Campisi G; Lo Russo L; Di Liberto C; Di Nicola F; Butera D; Vigneri S; Compilato D; Lo Muzio L; Di Fede O J Dent; 2008 Apr; 36(4):268-71. PubMed ID: 18313197 [TBL] [Abstract][Full Text] [Related]
51. Non-erosive reflux disease--defining the entity and delineating the management. Modlin IM; Hunt RH; Malfertheiner P; Moayyedi P; Quigley EM; Tytgat GN; Tack J; Holtmann G; Moss SF Digestion; 2008; 78 Suppl 1():1-5. PubMed ID: 18832833 [TBL] [Abstract][Full Text] [Related]
52. Salivary secretion in reflux esophagitis. Sonnenberg A; Steinkamp U; Weise A; Berges W; Wienbeck M; Rohner HG; Peter P Gastroenterology; 1982 Oct; 83(4):889-95. PubMed ID: 7106518 [TBL] [Abstract][Full Text] [Related]
53. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Farré R; van Malenstein H; De Vos R; Geboes K; Depoortere I; Vanden Berghe P; Fornari F; Blondeau K; Mertens V; Tack J; Sifrim D Gut; 2008 Oct; 57(10):1366-74. PubMed ID: 18593808 [TBL] [Abstract][Full Text] [Related]
55. The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. Fock KM; Teo EK; Ang TL; Tan JY; Law NM Clin Gastroenterol Hepatol; 2009 Jan; 7(1):54-9. PubMed ID: 18852068 [TBL] [Abstract][Full Text] [Related]
56. [Obesity, symptoms of gastroesophageal reflux and endoscopic findings in a referral hospital]. Peralta-Torres NM; Trujillo-Benavides OE; Paredes-Cruz E; Méndez-del Monte R; Baltazar-Montúfar Pde J Rev Gastroenterol Mex; 2007; 72(3):214-21. PubMed ID: 18402210 [TBL] [Abstract][Full Text] [Related]
57. Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects. Manabe N; Haruma K; Hata J; Kamada T; Kusunoki H Scand J Gastroenterol; 2008; 43(4):398-402. PubMed ID: 18365903 [TBL] [Abstract][Full Text] [Related]
58. Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Quigley EM Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):695-706. PubMed ID: 15324708 [TBL] [Abstract][Full Text] [Related]
60. Manometric study of lower esophageal sphincter in children with primary acid gastroesophageal reflux and acid gastroesophageal reflux secondary to food allergy. Semeniuk J; Kaczmarski M; Uścinowicz M Adv Med Sci; 2008; 53(2):283-92. PubMed ID: 18842562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]